These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27456942)

  • 1. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway.
    Kim B; Kim HS; Kim S; Haegeman G; Tsang BK; Dhanasekaran DN; Song YS
    Cancer Res Treat; 2017 Apr; 49(2):338-349. PubMed ID: 27456942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
    Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
    Colomiere M; Findlay J; Ackland L; Ahmed N
    Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.
    Wang L; Zhang F; Cui JY; Chen L; Chen YT; Liu BW
    Oncol Rep; 2018 May; 39(5):2081-2090. PubMed ID: 29565447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70.
    Xu NW; Chen Y; Liu W; Chen YJ; Fan ZM; Liu M; Li LJ
    Med Sci Monit; 2018 Sep; 24():6255-6263. PubMed ID: 30194286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [(*)AG490 could suppress bone marrow mesenchymal stem cells migration, mineralization and bone defect healing via inhibiting Jak2-STAT3 pathway].
    Yu X; Wan QL; Li Z; Li ZB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):293-300. PubMed ID: 29972985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of Kinase Inhibitor WP1066 on the STAT3/JAK2 of Prostate Stromal Cells].
    Li YX; Li JM; Wei Q; Zhang ZP; Wu J; Wang AG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):65-68. PubMed ID: 29737092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
    Guo YQ; Lu P; Duan ZF; Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells.
    Park GB; Kim D
    Neoplasia; 2019 Feb; 21(2):206-215. PubMed ID: 30622051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
    Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.
    Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M
    Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.
    Judd LM; Menheniott TR; Ling H; Jackson CB; Howlett M; Kalantzis A; Priebe W; Giraud AS
    PLoS One; 2014; 9(5):e95993. PubMed ID: 24804649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 is produced by adipose-derived stromal cells and promotes osteogenesis.
    Huh JE; Lee SY
    Biochim Biophys Acta; 2013 Dec; 1833(12):2608-2616. PubMed ID: 23830919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes.
    Kandalam U; Clark MA
    Regul Pept; 2010 Jan; 159(1-3):110-6. PubMed ID: 19748527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo treatment of rat arterial adventitia with interleukin‑1β induces intimal proliferation via the JAK2/STAT3 signaling pathway.
    Wang X; Chen L; Liu J; Yan T; Wu G; Xia Y; Zong G; Li F
    Mol Med Rep; 2016 Apr; 13(4):3451-8. PubMed ID: 26955959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.